Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, et al. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Mol Cancer. 2022;21:31.
Google Scholar
Jagadeeshan S, Prasad M, Badarni M, Ben Lulu T, Liju VB, Mathukkada S, et al. Mutated HRAS activates YAP1-AXL signaling to drive metastasis of head and neck cancer. Cancer Res. 2023;83:1031–47.
Wang Y, Chen Y, Zhang J, Yang Y, Fleishman JS, Wang Y, et al. Cuproptosis: a novel therapeutic target for overcoming cancer drug resistance. Drug Resist Updat. 2023;72:101018.
Google Scholar
Winardi D, Chu PY, Chen GY, Wang K, Hsu WY, Hsieh CL, et al. Novel aurora A kinase inhibitor fangchinoline enhances cisplatin-DNA adducts and cisplatin therapeutic efficacy in OVCAR-3 ovarian cancer cells-derived xenograft model. Int J Mol Sci. 2022;23:1868.
Google Scholar
Dasari S, Njiki S, Mbemi A, Yedjou CG, Tchounwou PB. Pharmacological effects of cisplatin combination with natural products in cancer chemotherapy. Int J Mol Sci. 2022;23:1532.
Google Scholar
Varna D, Geromichalou E, Karlioti G, Papi R, Dalezis P, Hatzidimitriou AG, et al. Inhibition of cancer cell proliferation and bacterial growth by silver(i) complexes bearing a CH(3)-substituted thiadiazole-based thioamide. Molecules. 2023;28:336.
Google Scholar
Xavier CPR, Belisario DC, Rebelo R, Assaraf YG, Giovannetti E, Kopecka J, et al. The role of extracellular vesicles in the transfer of drug resistance competencies to cancer cells. Drug Resist Updat. 2022;62:100833.
Google Scholar
Sai S, Koto M, Yamada S. Basic and translational research on carbon-ion radiobiology. Am J Cancer Res. 2023;13:1–24.
Google Scholar
Shi ZD, Hao L, Han XX, Wu ZX, Pang K, Dong Y, et al. Targeting HNRNPU to overcome cisplatin resistance in bladder cancer. Mol Cancer. 2022;21:37.
Google Scholar
Li F, Zheng Z, Chen W, Li D, Zhang H, Zhu Y, et al. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resist Updat. 2023;68:100938.
Google Scholar
Yamaguchi K, Yamamoto T, Chikuda J, Shirota T, Yamamoto Y. Impact of non-coding RNAs on chemotherapeutic resistance in oral cancer. Biomolecules. 2022;12:284.
Wang R, Ni C, Lou X, Zhang L, Wang L, Yao X, et al. IFNγ blockade in the capillary leak site improves tumour chemotherapy by inhibiting lactate-induced endocytosis of vascular endothelial cadherins. Int J Biol Sci. 2023;19:1490–508.
Google Scholar
Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C, et al. Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Res Treat. 2018;50:445–60.
Google Scholar
Lee J, You JH, Shin D, Roh JL. Inhibition of glutaredoxin 5 predisposes cisplatin-resistant head and neck cancer cells to ferroptosis. Theranostics. 2020;10:7775–86.
Google Scholar
Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J, et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun. 2022;42:88–116.
Google Scholar
Yu J, Zhong B, Zhao L, Hou Y, Ai N, Lu JJ, et al. Fighting drug-resistant lung cancer by induction of NAD(P)H: quinone oxidoreductase 1 (NQO1)-mediated ferroptosis. Drug Resist Updat. 2023;70:100977.
Google Scholar
Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21:47.
Google Scholar
Liu Y, Quan X, Li J, Huo J, Li X, Zhao Z, et al. Liposomes embedded with PEGylated iron oxide nanoparticles enable ferroptosis and combination therapy in cancer. Natl Sci Rev. 2023;10:nwac167.
Google Scholar
Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, et al. Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat. 2022;66:100916.
Google Scholar
Wang Q, Lv Q, Bian H, Yang L, Guo KL, Ye SS, et al. A novel tumor suppressor SPINK5 targets Wnt/β-catenin signaling pathway in esophageal cancer. Cancer Med. 2019;8:2360–71.
Google Scholar
Isharwal S, Manivel JC, Konety B. Penile cancer in a man with Netherton syndrome. Urology. 2015;85:e21–2.
Google Scholar
Di WL, Lwin SM, Petrova A, Bernadis C, Syed F, Farzaneh F, et al. Generation and clinical application of gene-modified autologous epidermal sheets in Netherton syndrome: lessons learned from a phase 1 Trial. Hum Gene Ther. 2019;30:1067–78.
Google Scholar
Liu J, Zhao J, Xu J, Sun Q, Qin X, Chen G, et al. SPINK5 is a prognostic biomarker associated with the progression and prognosis of laryngeal squamous cell carcinoma identified by weighted gene co-expression network analysis. Evol Bioinform Online. 2022;18:11769343221077118.
Google Scholar
Wu HT, Chen WT, Chen WJ, Li CL, Liu J. Bioinformatics analysis reveals that ANXA1 and SPINK5 are novel tumor suppressor genes in patients with oral squamous cell carcinoma. Transl Cancer Res. 2021;10:1761–72.
Google Scholar
Petrova E, López-Gay JM, Fahrner M, Leturcq F, de Villartay JP, Barbieux C, et al. Comparative analyses of Netherton syndrome patients and Spink5 conditional knock-out mice uncover disease-relevant pathways. Commun Biol. 2024;7:152.
Google Scholar
Zhu G, Wang W, Yao H, Li H, Zhang C, Meng Y, et al. Identification and validation of novel prognostic signatures based on m5C methylation patterns and tumor EMT profiles in head and neck squamous cell carcinoma. Sci Rep. 2023;13:18763.
Google Scholar
Li K, Xu N, Guo S. Multi-omics analysis of Siglec family genes in cutaneous melanoma. Front Immunol. 2023;14:1036019.
Google Scholar
Calcaterra V, Biganzoli G, Ferraro S, Verduci E, Rossi V, Vizzuso S, et al. A Multivariate analysis of “Metabolic Phenotype” patterns in children and adolescents with obesity for the early stratification of patients at risk of metabolic syndrome. J Clin Med. 2022;11:1856.
Google Scholar
Ali A, Iqbal MA, Abbas MW, Bouma GJ, Anthony RV, Anthony TE, et al. Trophectoderm transcriptome analysis in LIN28 knockdown ovine conceptuses suggests diverse roles of the LIN28-let-7 axis in placental and fetal development. Cells. 2022;11:1234.
Google Scholar
Lin Q, Zhu J, Chen J, Jia S, Nie S. Significance of cuproptosis- related genes in the diagnosis and classification of psoriasis. Front Mol Biosci. 2023;10:1115091.
Google Scholar
Chen B, Yao Y, Mao D, Li C, Wang X, Sheng S, et al. A signature based on costimulatory molecules for the assessment of prognosis and immune characteristics in patients with stomach adenocarcinoma. Front Immunol. 2022;13:928742.
Google Scholar
You J, Bian J, Chen J, Xia T, Deng A, Zhang M, et al. TNFSF15 and MIA variant associated with immunotherapy and prognostic evaluation in esophageal cancer. J Oncol. 2023;2023:1248024.
Google Scholar
Yu Z, Liu Z, Jiao L, Zhang S, Nie L, Wang Y, et al. Bmal1 knockdown in the left stellate ganglion inhibits neural activity and prevents ventricular arrhythmias after myocardial ischemia. Front Cardiovasc Med. 2022;9:937608.
Google Scholar
Qiao X, Lu Y, Xu J, Deng N, Lai W, Wu Z, et al. Integrative analyses of mRNA and microRNA expression profiles reveal the innate immune mechanism for resistance to Vibrio parahaemolyticus infection in Epinephelus coioides. Front Immunol. 2022;13:982973.
Google Scholar
Yang C, Wang W, Li S, Qiao Z, Ma X, Yang M, et al. Identification of cuproptosis hub genes contributing to the immune microenvironment in ulcerative colitis using bioinformatic analysis and experimental verification. Front Immunol. 2023;14:1113385.
Google Scholar
Xiang Q, Zhao Y, Li W. Identification and validation of ferroptosis-related gene signature in intervertebral disc degeneration. Front Endocrinol. 2023;14:1089796.
Google Scholar
Yao H, Zhang S, Xie H, Fan Y, Miao M, Zhu R, et al. RCN2 promotes Nasopharyngeal carcinoma progression by curbing Calcium flow and Mitochondrial apoptosis. Cell Oncol. 2023;46:1031–48.
Google Scholar
Paramanantham A, Asfiya R, Manjunath Y, Xu L, McCully G, Das S, et al. Induction of ferroptosis by an amalgam of extracellular vesicles and iron oxide nanoparticles overcomes cisplatin resistance in lung cancer. Preprint at https://doi.org/10.1101/2024.08.19.608664 2024.
Griso AB, Acero-Riaguas L, Castelo B, Cebrián-Carretero JL, Sastre-Perona A. Mechanisms of cisplatin resistance in hpv negative head and neck squamous cell carcinomas. Cells. 2022;11:561.
Google Scholar
Ferini G, Palmisciano P, Forte S, Viola A, Martorana E, Parisi S, et al. Advanced or metastatic cutaneous squamous cell carcinoma: the current and future role of radiation therapy in the era of immunotherapy. Cancers 2022;14:3210.
Google Scholar
Xu C, Jiang S, Ma X, Jiang Z, Pan Y, Li X, et al. CRISPR-based DNA methylation editing of NNT rescues the cisplatin resistance of lung cancer cells by reducing autophagy. Arch Toxicol. 2022;97:441–56.
Zhang C, Guo Q, Chen L, Wu Z, Yan XJ, Zou C, et al. A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors. Signal Transduct Target Ther. 2023;8:183.
Google Scholar
Khamis A, Gül D, Wandrey M, Lu Q, Knauer SK, Reinhardt C, et al. The Vitamin D receptor-BIM axis overcomes cisplatin resistance in head and neck cancer. Cancers (Basel) 2022;14:5131.
Google Scholar
Tyagi A, Kaushal K, Chandrasekaran AP, Sarodaya N, Das S, Park CH, et al. CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells. Theranostics. 2022;12:5949–70.
Google Scholar
Li Y, Lu Z, Che Y, Wang J, Sun S, Huang J, et al. Immune signature profiling identified predictive and prognostic factors for esophageal squamous cell carcinoma. Oncoimmunology. 2017;6:e1356147.
Google Scholar
Li RG, Deng H, Liu XH, Chen ZY, Wan SS, Wang L. Histone methyltransferase G9a promotes the development of renal cancer through epigenetic silencing of tumor suppressor gene SPINK5. Oxid Med Cell Longev. 2021;2021:6650781.
Google Scholar
Chen J, Lu J, Chen Z, Liu Z, Sun Y, He S, et al. SPINK5 inhibits esophageal squamous cell carcinoma metastasis via immune activity. J Gene Med. 2024;26:e3667.
Google Scholar
Gao X, Yang C, Li H, Shao L, Wang M, Su R. EMT-related gene risk model establishment for prognosis and drug treatment efficiency prediction in hepatocellular carcinoma. Sci Rep. 2023;13:20380.
Google Scholar
Orioli L, Canouil M, Sawadogo K, Ning L, Deldicque L, Lause P, et al. Identification of myokines susceptible to improving glucose homeostasis after bariatric surgery. Eur J Endocrinol. 2023;189:409–21.
Google Scholar
Guo Y, Yang N, Li G, Yin X, Dong L. Identification of an immune gene-based cisplatin response model and CD27 as a therapeutic target against cisplatin resistance for ovarian cancer. J Immunol Res. 2022;2022:4379216.
Google Scholar
Wang N, Zhu L, Wang L, Shen Z, Huang X. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Comput Struct Biotechnol J. 2022;20:3106–19.
Google Scholar
Kalathil AA, Guin S, Ashokan A, Basu U, Surnar B, Delma KS, et al. New pathway for cisplatin prodrug to utilize metabolic substrate preference to overcome cancer intrinsic resistance. ACS Cent Sci. 2023;9:1297–312.
Google Scholar
Sun S, Su G, Zheng X. Inhibition of the tumor suppressor gene SPINK5 via EHMT2 induces the oral squamous cell carcinoma development. Mol Biotechnol. 2024;66:208–21.
Google Scholar
Liu H, Huang Q, Lv Y, Dong Y, Song D. CEBPB knockdown sensitizes nasopharyngeal carcinoma cells to cisplatin by promoting the expression of serine protease inhibitor Kazal-type 5. Anticancer Drugs. 2022;33:e327–35.
Google Scholar
Tang B, Yan R, Zhu J, Cheng S, Kong C, Chen W, et al. Integrative analysis of the molecular mechanisms, immunological features and immunotherapy response of ferroptosis regulators across 33 cancer types. Int J Biol Sci. 2022;18:180–98.
Google Scholar
Gui CP, Li JY, Fu LM, Luo CG, Zhang C, Tang YM, et al. Identification of mRNA vaccines and conserved ferroptosis-related immune landscape for individual precision treatment in bladder cancer. J Big Data. 2022;9:88.
Google Scholar
Rabitha R, Shivani S, Showket Y, Sudhandiran G. Ferroptosis regulates key signaling pathways in gastrointestinal tumors: Underlying mechanisms and therapeutic strategies. World J Gastroenterol. 2023;29:2433–51.
Google Scholar
Tseng HC, Kuo CY, Liao WT, Chou TS, Hsiao JK. Indocyanine green as a near-infrared theranostic agent for ferroptosis and apoptosis-based, photothermal, and photodynamic cancer therapy. Front Mol Biosci. 2022;9:1045885.
Google Scholar
Li WY, Wan JJ, Kan JL, Wang B, Song T, Guan Q, et al. A biodegradable covalent organic framework for synergistic tumor therapy. Chem Sci. 2023;14:1453–60.
Google Scholar
Wu J, Cai H, Lei Z, Li C, Hu Y, Zhang T, et al. Expression pattern and diagnostic value of ferroptosis-related genes in acute myocardial infarction. Front Cardiovasc Med. 2022;9:993592.
Google Scholar
